Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    preferms
Show Display Options
Rank Status Study
1 Completed Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Disease Modifying therapy

Study has passed its completion date and status has not been verified in more than two years.